API | tanezumab

tanezumab Report issue

Biologics mAb Experimental

AACT ChEMBL DrugBank MeSH

Active Ingredient History

NOW

Tanezumab is a monoclonal antibody against nerve growth factor as a treatment for pain via a novel mechanisms different from conventional pain-killer drugs. Tanezumab was discovered and developed by Rinat Neuroscience and was acquired by Pfizer in 2006. ^Wikipedia

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecule:
tanezumab

More Chemistry

Pharmacology

Mechanisms of Action:
- Beta-nerve growth factor (Homo sapiens) ^UniProt
- Beta-nerve growth factor (Homo sapiens) ^UniProt
Multi-specific: No
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

anti-ngf ab | pf04383119 | pf 04383119 | pf-04383119 | pf4383119 | pf 4383119 | pf-4383119 | ri 624 | ri-624 | ri624 mab | rn624 | rn 624 | rn-624 | rn624 mab | tanezumab

Organizations (51)

Research & Development (51)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (20)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (20)

Arthritis (Phase 3)

Back Pain (Phase 1)

Cancer Pain (Phase 3)

Chronic Pain (Phase 3)

Cystitis, Interstitial (Phase 2)

Diabetes Mellitus (Phase 2)

Endometriosis (Phase 2)

Healthy Volunteers (Phase 1)

Low Back Pain (Phase 3)

Neoplasm Metastasis (Phase 3)

Neoplasms (Phase 2)

Neuralgia, Postherpetic (Phase 2)

Osteoarthritis (Phase 3)

Osteoarthritis, Hip (Phase 3)

Osteoarthritis, Knee (Phase 3)

Pain (Phase 3)

Palliative Care (Phase 2)

Pancreatitis, Chronic (Phase 2)

Prostatitis (Phase 2)

Schwann Cells (Phase 2)

Overview

Highest Phase: Phase 3
# of Trials: 38
# of Trial Organizations: 51

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue